Skip to main content
Ari Baron, MD, Oncology, San Francisco, CA, California Pacific Medical Center-Davies Campus

AriDBaronMD

Oncology San Francisco, CA

Gastrointestinal Cancer, Genitourinary Oncology, Hematologic Oncology

Chief, Division of Hematology-Oncology, California Pacific Medical Center Associate Clinical Professor, Medicine, UCSF

Dr. Baron is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Baron's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)/Fresno
    University of California (San Francisco)/FresnoFellowship, Hematology and Medical Oncology, 1994 - 1996
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1991 - 1993
  • University of California (San Francisco)
    University of California (San Francisco)Internship, Internal Medicine, 1990 - 1991
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1990
  • Wesleyan University
    Wesleyan UniversityB.A., English, 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1991 - 2025

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013
  • Excellence in Teaching Award, Department of Medicine (Awarded to Outstanding Teacher among Clinical Fellows by Medicine House Staff) University of California, San Francisco, 1995
  • Julius Krevans Award for Clinical Excellence, Department of Medicine (Awarded to Outstanding Intern) University of California, San Francisco, 1991
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors  
    Maison-Blanche P, Dakhil S, Baron A, Rottey S, Millard F, Daugaard G, Machiels JP, Conkright W, Sharma S, Soetekouw PM, Yachnin J, Sengelov L, Van Veldhuizen P, Agarwa..., Cancer Chemother Pharmacol, 1/1/2014
  • Lenalidomide and Rituximab in Waldenstrom’s Macroglobulinemia  
    Steven P. Treon, Jacob D. Soumerai, Andrew R. Branagan, Zachary R. Hunter, Christopher J. Patterson, Leukothea Ioakimidis, Luis Chu, Paul Musto, Ari D. Baron, Johannes..., Clinical Cancer Res, 1/1/2009
  • Phase II Trial of Weekly Patupilone (EPO 906) in Patients with Castration-Resistant Prostate Cancer  
    Hussain, DiPaola, Baron, Higano, Tchekmedyian, Miller, Rothermel, Annals of Oncology, 1/1/2009
  • Join now to see all

Abstracts/Posters

  • Ramucirumab as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Analysis of Patients with Elevated ?-Fetoprotein from the Randomized Phase II...
    Andrew X. Zhu, Baek-Yeol Ryoo, Chia-Jui Yen, Masatoshi Kudo, Ronnie Poon, Davide Pastorelli, Jean-Frederic Blanc, Hyun Cheol Chung, Ari D. Baron, Tulio Eduardo Flesch ..., Proc ASCO/GI, 1/1/2015
  • The DASH Study: A Phase 1b Study of Dalantercept Plus Sorafenib in Advanced Hepatocellular Carcinoma
    Ghassan K Abou-Alfa, Rebecca A. Miksad, Martin E. Gutierrez, Mohamedtaki A. Tejani, Manish R. Sharma, Weijing Sun, Charles A. Henderson, Ari D. Baron, Olugbenga O. Olo..., Proc ASCO/GI, 1/1/2015
  • Ramucirumab(RAM) as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC); Analysis of Patient’s by Child-Pugh Score
    Ian Chau, Ari David Baron, Peter Malfertheiner, Masatoshi Kudo, Seiji Kawazoe, Denis Pezet, Florian Weissinger, Giovanni Brandi, Carlo Barone, Takuji Okusaka, Yoshiyuk..., Proc ASCO, 1/1/2015
  • Join now to see all

Professional Memberships

Hospital Affiliations